News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Donley Matthew Maxwell
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Donley Matthew Maxwell (EVP, Ops & Strategy) has filed a Form 4 on Aurinia Pharmaceuticals Inc.|
Txns:
| Granted 271,134 shares
@ $0 |
|
| 11/23/2022 |
4
| Donley Matthew Maxwell (Ex VP, Internal Operations) has filed a Form 4 on Aurinia Pharmaceuticals Inc.|
Txns:
| Bought 10,000 shares
@ $4.66, valued at
$46.6k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2018 |
4
| Donley Matthew Maxwell (EVP, Global HR, IT & Strategy) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 36,975 shares
@ $18, valued at
$665.6k
Disposed/sold 150,000 options to buy
@ $7.4, valued at
$1.1M
Disposed/sold 25,000 options to buy
@ $6.75, valued at
$168.8k
Disposed/sold 28,000 options to buy
@ $14.82, valued at
$415k
Disposed/sold 75,000 options to buy
@ $13.8, valued at
$1M
Disposed/sold 101,000 options to buy
@ $11.85, valued at
$1.2M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2018 |
4
| Donley Matthew Maxwell (EVP, Global HR, IT & Strategy) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 19,353 shares
@ $17.98, valued at
$348k
|
|
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
4
| Donley Matthew Maxwell (EVP, Human Resources) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 53,000 shares
@ $0
Granted 101,000 options to buy
@ $11.85, valued at
$1.2M
|
|
| 01/06/2017 |
4
| Donley Matthew Maxwell (Exec.VicePres,HumanResources) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 286 shares
@ $10.46, valued at
$3k
|
|
| 10/21/2016 |
4
| Donley Matthew Maxwell (Exec.VicePres,HumanResources) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 320 shares
@ $9.38, valued at
$3k
|
|
| 07/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|